Masandang, Rosalina G.

HRN: 26-68-69  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/13/2025
02/20/2025
IV
600mg
Q6
Herpes Zoster
Waiting Final Action 
02/13/2025
MUPIROCIN 2%, 15G (TUBE)
02/13/2025
02/20/2025
IV
600mg
Q6
Herpes Zoster
Rejected 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: